Fujie previously worked at Deloitte & Touche, LLP for 32 years, including 10 years as Managing Partner in Hawai'i. His clients have included Alexander & Baldwin, Kamehameha Schools, Maui Land & Pineapple Company, Queen's Health Systems, and Servco Pacific. He earned both his bachelor and master degrees in business administration at the University of Hawai'i.

"I am pleased and honored to join HPU. I have assisted HPU with its fund-raising for several years, and was always impressed with its outstanding performance as a private university and with its leadership," Fujie said.

Hawaii Biotech raises $7.8 million from investors

Hawaii Biotech Inc. announced today that it has raised $7.8 million from Hawai'i-based and Mainland investors to help fund some of its programs, including the pre-clinical and early clinical development of Cardax, the company's treatment for cardiovascular inflammatory disease.

In connection with the funding, Hawaii Biotech Board Chairman Nick Mitsakos announced the addition of two new members to the board: Frank Herringer, chairman and former chief executive officer of Transamerica Corp. and a Board member of Amgen and Charles Schwab; and Dick Foster, former founder and leader of the healthcare practice at McKinsey & Company.

Solomon Enos to address Native Hawaiian Chamber of Commerce

Solomon Enos, artist, illustrator and cultural activist, will be the featured speaker at the Native Hawaiian Chamber of Commerce's luncheon meeting on Jan. 19 at the Pacific Club.